Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 15,180 shares at $8.14 ($124K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Seasonal sale ($124k) by Executive VP, Global R&D — this insider has traded TEVA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.14 | 7,590 | $62K | 50.0% |
| 2 | $8.14 | 7,590 | $62K | 50.0% |
| Total | $8.14 avg | 15,180 | $124K | 100% |
| Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |
| TEVA | SELL | 2021-05-13 | $390K | — | Filing → |